Literature DB >> 21087069

Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study.

Kathleen M Mazor1, Sarah Velten, Susan E Andrade, Robert A Yood.   

Abstract

BACKGROUND: Osteoporosis is a significant health problem, especially for older women. Prescription osteoporosis medication can reduce fractures, but many women do not accept treatment or discontinue treatment before benefits are achieved.
OBJECTIVES: To explore older women's views about prescription osteoporosis medication use in depth and to identify specific beliefs and experiences that influence these views.
METHODS: We conducted in-depth telephone interviews with women aged ≥65 years with clinically confirmed osteoporosis. Interviewees were asked about their beliefs and experiences related to osteoporosis and osteoporosis treatment. Interviews were recorded and transcribed; key themes were identified using qualitative analysis.
RESULTS: Perceived need, medication effectiveness and medication safety were identified as critical influences on women's views about prescription osteoporosis medication. These perceptions were in turn influenced by various beliefs, experiences and behaviours, including interactions with the physician, personal experience and behaviours, and vicarious experience.
CONCLUSIONS: Older women with osteoporosis need clear information about their condition, including the diagnosis, the implications of the diagnosis, treatment options, medication effectiveness and side effects. Physicians should check with their patients to confirm understanding and address concerns, as older women may not always voice their reservations and concerns.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087069     DOI: 10.2165/11584790-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  17 in total

Review 1.  The Medication Adherence Model: a guide for assessing medication taking.

Authors:  Mary Jayne Johnson
Journal:  Res Theory Nurs Pract       Date:  2002       Impact factor: 0.688

2.  Compliance with osteoporosis medications.

Authors:  Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Joel S Finkelstein; Marilyn Arnold; Jennifer M Polinski; M Alan Brookhart
Journal:  Arch Intern Med       Date:  2005-11-14

3.  Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

Authors:  Ethel S Siris; Steven T Harris; Clifford J Rosen; Charles E Barr; James N Arvesen; Thomas A Abbott; Stuart Silverman
Journal:  Mayo Clin Proc       Date:  2006-08       Impact factor: 7.616

4.  The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.

Authors:  Colleen A McHorney; John T Schousboe; Richard R Cline; Thomas W Weiss
Journal:  Curr Med Res Opin       Date:  2007-12       Impact factor: 2.580

5.  Compliance with pharmacologic therapy for osteoporosis.

Authors:  Robert A Yood; Srinivas Emani; John I Reed; Barbara Edelman Lewis; Mary Charpentier; Eva Lydick
Journal:  Osteoporos Int       Date:  2003-09-19       Impact factor: 4.507

6.  Compliance with drug therapies for the treatment and prevention of osteoporosis.

Authors:  Jeffrey S McCombs; Patrick Thiebaud; Connie McLaughlin-Miley; Jinhai Shi
Journal:  Maturitas       Date:  2004-07-15       Impact factor: 4.342

7.  Early discontinuation of treatment for osteoporosis.

Authors:  Anna N A Tosteson; Margaret R Grove; Cristina S Hammond; Megan M Moncur; G Thomas Ray; Gwen M Hebert; Alice R Pressman; Bruce Ettinger
Journal:  Am J Med       Date:  2003-08-15       Impact factor: 4.965

8.  Fracture outcomes related to persistence and compliance with oral bisphosphonates.

Authors:  Arlene M Gallagher; Stephan Rietbrock; Melvin Olson; Tjeerd P van Staa
Journal:  J Bone Miner Res       Date:  2008-10       Impact factor: 6.741

9.  Consequences of poor compliance with bisphosphonates.

Authors:  Becky A Briesacher; Susan E Andrade; Robert A Yood; Kristijan H Kahler
Journal:  Bone       Date:  2007-07-18       Impact factor: 4.398

10.  Loss of treatment benefit due to low compliance with bisphosphonate therapy.

Authors:  F J A Penning-van Beest; J A Erkens; M Olson; R M C Herings
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

View more
  14 in total

1.  Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.

Authors:  Katie Qi; Emily Reeve; Sarah N Hilmer; Sallie-Anne Pearson; Slade Matthews; Danijela Gnjidic
Journal:  Int J Clin Pharm       Date:  2015-06-06

2.  Learning from marketing: Rapid development of medication messages that engage patients.

Authors:  Veronica Yank; Erika Tribett; Lydia Green; Jasmine Pettis
Journal:  Patient Educ Couns       Date:  2015-03-14

Review 3.  Systematic scoping review of patients' perceived needs of health services for osteoporosis.

Authors:  L Chou; P Shamdasani; A M Briggs; F M Cicuttini; K Sullivan; K L M D Seneviwickrama; A E Wluka
Journal:  Osteoporos Int       Date:  2017-07-31       Impact factor: 4.507

Review 4.  Patients' expectations of medicines--a review and qualitative synthesis.

Authors:  Ulrica Dohnhammar; Joanne Reeve; Tom Walley
Journal:  Health Expect       Date:  2015-02-01       Impact factor: 3.377

Review 5.  A qualitative systematic review of patients' experience of osteoporosis using meta-ethnography.

Authors:  K L Barker; F Toye; C J Minns Lowe
Journal:  Arch Osteoporos       Date:  2016-10-13       Impact factor: 2.617

6.  Women's lived experiences of learning to live with osteoporosis: a longitudinal qualitative study.

Authors:  Carrinna A Hansen; Bo Abrahamsen; Hanne Konradsen; Birthe D Pedersen
Journal:  BMC Womens Health       Date:  2017-03-09       Impact factor: 2.809

7.  Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use.

Authors:  Michael J Miller; Tzuchen Jou; Maria I Danila; Amy S Mudano; Elizabeth J Rahn; Ryan C Outman; Kenneth G Saag
Journal:  Res Social Adm Pharm       Date:  2020-09-20

8.  Reasons for not initiating osteoporosis therapy among a managed care population.

Authors:  Jingbo Yu; Susan K Brenneman; Vasilisa Sazonov; Ankita Modi
Journal:  Patient Prefer Adherence       Date:  2015-06-19       Impact factor: 2.711

9.  A weighty matter: heaviness influences the evaluation of disease severity, drug effectiveness, and side effects.

Authors:  Kai Kaspar
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  Application of the health belief model and social cognitive theory for osteoporosis preventive nutritional behaviors in a sample of Iranian women.

Authors:  Ali Khani Jeihooni; Alireza Hidarnia; Mohammad Hossein Kaveh; Ebrahim Hajizadeh; Alireza Askari
Journal:  Iran J Nurs Midwifery Res       Date:  2016 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.